Weight loss drugs are everywhere and recently Zepbound (tirzepitide) made big news when it became the first FDA-approved sleep apnea therapy for mild to moderate sleep apnea. In this episode, we will:Introduce and explain weight loss medicationsReview the studies that convinced the FDA to approve Zepbound for sleep apneaProvide an overview on this class of weight loss medicationsEvaluate the risks and determine who is a best match for this therapyTouch on the cost and difficulty in getting these drugs approvedRevisit Apnimed's SynAIRgy press release and how it relates to our discussion in episode 110 of the podcastProduced by: Maeve WinterMore Twitter: @drchriswinter IG: @drchriwinter Threads: @drchriswinter Bluesky: @drchriswinter The Sleep Solution and The Rested Child Thanks for listening and sleep well!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related